Seamless Transitions: Supporting Patients Through Treatment, Monitoring, and Maintenance

Panelists discuss how industry-provided patient support services can assist patients receiving bispecific antibodies, particularly in monitoring and follow-up care, and how these services can support patients transitioning from active treatment to maintenance or posttreatment care.

EP: 1.Challenges at Diagnosis: Navigating the Emotional and Physical Realities of DLBCL and FL

EP: 2.Empowering Patients: Strategies for Emotional Resilience and Support in Lymphoma Care

EP: 3.Tailored Support: The Role of Industry-Provided Services in Lymphoma Care

Now Viewing

EP: 4.Seamless Transitions: Supporting Patients Through Treatment, Monitoring, and Maintenance

EP: 5.Innovations and Impact: The Future of Patient Support Services in Hematology-Oncology

Video content above is prompted by the following:

What role would these services play in assisting patients receiving bispecific antibodies, particularly regarding monitoring and follow-up care to ensure optimal outcomes?
How can industry-provided patient support services help patients transition from active treatment to maintenance or posttreatment care?

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!